WebChinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe … Web2 days ago · SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that dosing in the phase 1 clinical trial of CHK-336 in healthy volunteers has been voluntarily paused …
Chinook Therapeutics Announces Voluntary Pause in Dosing of …
WebOct 5, 2024 · Chinook seeks to build its pipeline by leveraging insights in kidney single cell RNA sequencing, human-derived organoids and new translational models, to discover … WebHeadquarters. Nottingham, England, New Jersey, USA. Key people. CEO : Rifat Chalabi Founders : Rifat Chalabi, Harry Perry, Fanli Meng. Number of employees. ~240. … domino pizza menu list uk
Chinook Therapeutics to merge with Aduro Biotech as it
WebInformation on stock, financials, earnings, subsidiaries, investors, and executives for Chinook Therapeutics. Use the PitchBook Platform to explore the full profile. ... Chinook Therapeutics Inc is a clinical-stage biotechnology company. The products of the company are focused on rare, severe chronic kidney disorders. ... Seattle, WA 98164 ... WebJun 5, 2024 · Chinook Therapeutics, a biotech company creating targeted therapies for kidney diseases, has agreed to merge with Berkeley, Calif.-based Aduro Biotech. WebAug 20, 2024 · Chinook, which began as a 15-person company two years ago, plans to have between 75 and 100 employees by the end of the year, Dobmeier said. It raised $65 million in a Series A round in August 2024. domino pizza plaza acevedo